Navigation Links
Danaher Reports Record First Quarter 2013 Results
Date:4/18/2013

WASHINGTON, April 18, 2013 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations unless otherwise noted.

Net earnings for the quarter ended March 29, 2013 were $691.9 million, or $0.98 per share on a diluted basis, a 34% increase over diluted net earnings per share of $0.73 for the first quarter 2012.  As summarized in the attached reconciliation, first quarter 2013 earnings from continuing operations include gains from the sale of the Apex Tool Group LLC joint venture and discrete tax benefits. Excluding these gains, adjusted diluted earnings per share from continuing operations for the quarter ended March 29, 2013 were $0.75, a 2.5% increase over the comparable amount in the first quarter of 2012.

Sales for the 2013 first quarter were $4.4 billion, 3% higher than the $4.3 billion reported for the 2012 first quarter.  Core revenues increased 1.0% in the first quarter of 2013 compared to the first quarter of 2012.

The Company anticipates that GAAP diluted net earnings per share for the quarter ending June 28, 2013 will be in the range of $0.80 to $0.85.  The Company reaffirmed its full year 2013 adjusted diluted net earnings per share guidance of $3.32 to $3.47. 

H. Lawrence Culp, Jr. , President and Chief Executive Officer, stated, "Our modest expectations for global growth heading into this year have, so far, played out largely as anticipated.  The Danaher Business System continues to help us drive share gains, margins and cash flow in this low growth environment. We believe our solid recurring revenue base, the structural cost actions executed in 2012 and an attractive acquisition environment position Danaher well for the balance of 2013 a
'/>"/>

SOURCE Danaher Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Danaher Reports Record Fourth Quarter 2012 Results
2. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
3. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
4. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
5. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
6. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
7. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
8. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
9. Luminex Corporation Reports First Quarter 2012 Results
10. Hospira Reports First-Quarter 2012 Results
11. Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Aug. 31, 2015  On August 5, 2015, the ... Oregon denied motions to dismiss securities class ... ) and certain of its directors. The class actions ... and dump" scheme to artificially inflate Galena,s stock price, ... stock price was inflated, sold massive amounts of their ...
(Date:8/31/2015)... , Aug. 31, 2015  Regulatory affairs ... government, where regulations are often strict and legislation ... driving a demand for professionals who have a ... regulations across a product lifecycle and demonstrate its ... University of California, Irvine Extension , in ...
(Date:8/31/2015)... SAN DIEGO , Aug. 31, 2015 ... announced today development of a novel means of ... nucleic acid, RGBP-248, to liver tumors utilizing a ... in development overcomes previous hurdles with gene silencing ... to be delivered throughout the whole body.  By ...
Breaking Medicine Technology:Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ... that Acetadote® ( acetylcysteine ) Injection, an injectable product ... available in the Australian market. Phebra Pty Ltd., an ... U.S.-based Cumberland Pharmaceuticals to market and distribute the product ...
... Biotechnology Corporation (Nasdaq: GNBT ) ( www.generex.com ) ... reverse stock split proposal put forward at the Annual Meeting ... DO NOT COUNT as votes cast in respect of ... Special Meeting of stockholders scheduled for 10 a.m. EDT on ...
Cached Medicine Technology:Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 2Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 3Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 4Cumberland Pharmaceuticals and Phebra Pty Ltd. Announce the Launch of Acetadote® in Australia 5Generex Provides Clarification for Special Meeting Voting 2Generex Provides Clarification for Special Meeting Voting 3
(Date:8/31/2015)... , ... August 31, 2015 , ... Coast Dental ... September 5, 2015, from 11 a.m. to 3 p.m. near Albertsons in the Foothill ... opportunity to meet Dr. Ofelia Rivera and Dr. Jay Lopp. Call (760) 208-2518 for ...
(Date:8/31/2015)... ... 2015 , ... Neuropsychiatric Disease and Treatment has ... near-infrared laser phototherapy ”. , As corresponding author Dr Theodore Henderson says “These ... with mostly palliative treatments only - and now we have shown real clinical ...
(Date:8/31/2015)... Scotch Plains, NJ (PRWEB) , ... August 31, 2015 , ... NJ Top Docs Presents, ... Doc”!, Born and raised in Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don ... and ice hockey and served as team captain in both sports in his senior year. ...
(Date:8/31/2015)... ... August 31, 2015 , ... How ... and others—to hold down costs? , In a commentary for The American ... presents the concept of “clinical efficacy,” which would bind parties together in agreements ...
(Date:8/31/2015)... ... August 31, 2015 , ... The dental implant and prosthetic market ... Academy of Implant Dentistry. (See Press Room ) More than 30 million Americans ... procedure. With the increasing demand for dental implants, the National Association of Dental Laboratories ...
Breaking Medicine News(10 mins):Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4
... March 14 Sergeant,s Pet Care Products,today ... division of Virbac,Corporation. The brands and technology ... that include internal and external health care,products, ... Well recognized,brands include WormXPlus(TM), WormX(R), Petrodex(R), Zema(R), ...
... Ky. (Mar. 14, 2008) − Transcendental Meditation is ... with the added benefit of bypassing possible side ... a new meta-analysis conducted at the University of ... of the American Journal of Hypertension. , The ...
... the laboratory suggests that a new compound can point the ... latent form of the bacterium, says a team led by ... A drug with such properties could also be useful in ... treatment period. The discovery also points to new ways of ...
... at The University of Nottingham say modern matrons ... to fulfil their role as leader, and this remains ... healthcare. , Researchers at the Institute for Science and ... and unless significant budgetary responsibility is made part of ...
... ... Awareness Month, LOS ANGELES, March 14 Award-winning singer ... Valvo, who,is a colon cancer survivor, appear in a new ... The PSAs also note that,with advances in treatment, more people ...
... Serwik to Visit Washington, D.C., and Meet with Elected ... Del. will travel to Washington, D.C., this April 1 ... restoration of the,Americans with Disabilities Act, support for epilepsy ... epilepsy., Serwik, 7, is one of 50 young ...
Cached Medicine News:Health News:Sergeant's(R) Pet Care Products Acquires the Consumer Brand Division of Virbac Corporation 2Health News:New chemical can kill latent tuberculosis bacteria 2Health News:New chemical can kill latent tuberculosis bacteria 3Health News:Modern matron struggling to fulfil role as leader 2Health News:Vanessa Williams and Carmen Marc Valvo Make It Fashionable to Talk About Colon Cancer In New Public Service Announcement 2Health News:Vanessa Williams and Carmen Marc Valvo Make It Fashionable to Talk About Colon Cancer In New Public Service Announcement 3Health News:Delaware Youth Named National Epilepsy Spokesperson 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: